Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 87Thoracic 8Gastrointestinal 7Genitourinary 6Head & Neck 5Gynecologic 5Sarcoma 2Dermatologic 2Plasma cell 1Other solid neoplasm 1CNS 1

Conditions

Multiple Myeloma 130Neoplasms, Plasma Cell 16Recurrence 14Lymphoma 10Neoplasms 9Immunoglobulin Light-chain Amyloidosis 8Monoclonal Gammopathy of Undetermined Significance 5Leukemia, Plasma Cell 5Hematologic Neoplasms 5Waldenstrom Macroglobulinemia 3Smoldering Multiple Myeloma 3Paraproteinemias 3Leukemia 3Respiratory Aspiration 2Ovarian Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Kidney Neoplasms 2Hypoventilation 2Gastrointestinal Neoplasms 2Disease 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Amyloidosis 2Venous Thromboembolism 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Taste Disorders 1

Interventions

pembrolizumab 1daratumumab 1Paclitaxel 1Lenalidomide 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Carboplatin 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Triple Negative Breast Neoplasms × Plasma cell × Clear all
NCT07341867 2026-01-14

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

Dana-Farber Cancer Institute

Phase 1 Not yet recruiting
90 enrolled
BreastPlasma cell

Multiple Myeloma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡